Lazela 375 mg, tabletten met verlengde afgifte

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127793_smpc_en.pdf",
  "strength": null,
  "atc_label": "Ranolazine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127793",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMHYDROXIDE (E 524)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "RANOLAZINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127793_piluk.pdf",
  "authorised_at": "2022/07/21",
  "procedure_number": "NL/H/5343/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127793",
  "additional_monitoring": "N"
}